LMA, which is headquartered in Singapore, designs, manufactures, markets and distributes the LMA laryngeal mask airway range of supraglottic airway devices and LMA atomization devices for administration of medication.
Teleflex also announced it completed its previously announced agreement with the shareholders of Intavent Direct Limited and affiliates to acquire the LMA branded laryngeal mask supraglottic airway business and certain other products in the United Kingdom, Ireland and Channel Islands.
“These acquisitions will be complementary to Teleflex’s current anesthesia and respiratory businesses, creating a stronger, more diversified business segment with more than $530 million in combined annual sales,” said Benson Smith, chairman, president and CEO, in an earlier news release. “The addition of these businesses significantly strengthens and expands our global anesthesia product portfolio, providing opportunities with respect to key clinical U.S. and international call points, while also further strengthening our GPO relationships.”
Teleflex is headquartered in Limerick, Pa.
Related Articles on Company Acquisitions:
Helix Medical Acquires MedVenture Technology
